Señales en vivo de FEMY | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	62 179.00
Volumen promedio	725 713
Capitalización de mercado	28.66M
EPS	$0 ( 2024-04-04 )
Próxima fecha de ganancias	( $-0.220 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.390
ATR14	$0.00600 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-12	Spector Richard D.	Buy	100 000	Stock Option (Right to Buy)
2024-02-12	Spector Richard D.	Buy	0
2024-02-01	Currie Daniel Scott	Buy	61 900	Stock Option (Right to Buy)
2024-02-01	Elefant Dov	Buy	84 000	Stock Option (Right to Buy)
2024-02-01	Thomas Christine E	Buy	32 600	Stock Option (Right to Buy)

INSIDER POWER
-78.98
Last 82 transactions
Buy: 6 908 475 \| Sell: 19 734 221

Volumen Correlación

Largo: -0.10 (neutral)

Corto: -0.82 (strong negative)

Signal:(61.791) Neutral

Femasys Inc. Correlación

10 Correlaciones Más Positivas
POWL	0.929
VEON	0.922
ALRM	0.917
OCUL	0.917
IOVA	0.916
CLBT	0.915
TARA	0.91
PXLW	0.906
QRTEA	0.905
PEPG	0.905

10 Correlaciones Más Negativas
DCRC	-0.919
SGLB	-0.904
CYAN	-0.873
SSRM	-0.868
DSWL	-0.859
GIGM	-0.859
BLKB	-0.858
GRNA	-0.855
DSPC	-0.85
WTER	-0.846

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Femasys Inc. Correlación - Moneda/Commodity

0.19
( neutral )

-0.30
( neutral )

0.00
( neutral )

0.66
( moderate )

Femasys Inc. Finanzas

Annual	2023
Ingresos:	$1.07M
Beneficio Bruto:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2023
Ingresos:	$1.07M
Beneficio Bruto:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2022
Ingresos:	$1.21M
Beneficio Bruto:	$764 280 (63.36 %)
EPS:	$-0.970

FY	2021
Ingresos:	$1.18M
Beneficio Bruto:	$809 305 (68.60 %)
EPS:	$-0.831

Financial Reports:

No articles found.

Femasys Inc.

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Actualizaciones en tiempo real para Femasys Inc. [FEMY]

Upcoming Earnings Alert